Additionally, antibody inhibition experiments supported a key role of CXCR1/2 in the migration process of CRC cells, which suggested that CXCL8 and its receptors improved the metastatic potential along with the migration ability of CRC cells. Here, CXCL8 is linked to colorectal carcinoma.